Role of nitric oxide in NMDA-evoked release of [3H]-dopamine from striatal slices

Neuroreport. 1992 May;3(5):409-12. doi: 10.1097/00001756-199205000-00008.

Abstract

Evidence that excitatory amino acids act via N-methyl-D-aspartate (NMDA) receptors to evoke the release of catecholamines from axonal terminals and synaptosomes has been used to argue for the presence of pre-synaptic NMDA receptors. NMDA receptor agonists also generate nitric oxide (NO) which rapidly diffuses through neural tissue. We find that exogenously applied NO evokes [3H]-dopamine release from cultured neurons. This release is not blocked by the NMDA antagonist MK-801 nor by tetrodotoxin. Both NG-nitroarginine which inhibits NO synthesis, and hemoglobin which binds extracellular NO, block NMDA-evoked [3H]-dopamine release from striatal slices. A major role of endogenously-synthesized NO may be to evoke neurotransmitter release in local volumes of neural tissue.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cells, Cultured
  • Corpus Striatum / metabolism*
  • Dopamine / metabolism*
  • Female
  • In Vitro Techniques
  • N-Methylaspartate / pharmacology*
  • Nitric Oxide / metabolism*
  • Rats
  • Rats, Inbred Strains
  • Tritium

Substances

  • Tritium
  • Nitric Oxide
  • N-Methylaspartate
  • Dopamine